Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

World Needs "Revolution" in Mental Health Care, U.N. Health Rights Expert Reports

Human Rights group says overhaul of psycho-pharmaceutical industry should begin with investigation into the drugging of 6- 12-year-olds


News provided by

Citizens Commission on Human Rights

Jun 14, 2017, 09:00 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, June 14, 2017 /PRNewswire/ -- A United Nations Health Rights expert, Dr. Dainius Pūras, has issued a report calling for mental health care to move away from a biomedical (drug) model. The mental health industry watchdog Citizens Commission on Human Rights says the drug model has led to 8.4 million children — 1 million aged five or younger — being prescribed psychiatric drugs in the U.S. alone.

Continue Reading
Citizens Commission on Human Rights International
Citizens Commission on Human Rights International

The United Nations Special Rapporteur on the right to health, Dr. Dainius Pūras, has called for a revolution in mental health care around the world to "end decades of neglect, abuse and violence," he said after presenting his latest report to the U.N. Human Rights Council in Geneva.[1] "There is now unequivocal evidence of the failures of a system that relies too heavily on the biomedical model of mental health services, including the front-line and excessive use of psychotropic medicines, and yet these models persist," Dr. Pūras, head of the Centre for Child Psychiatry Social Pediatrics at Vilnius University, Lithuania, said.

Between 2007 and 2011, Dr. Pūras also served as a member of the U.N. Committee on the Rights of the Child (UNCRC), which held hearings on the increasing rate of children being labeled with Attention Deficit Hyperactivity Disorder (ADHD) and drugged with psychostimulants.[2]

Mental health watchdog Citizens Commission on Human Rights (CCHR) presented submissions to the UNCRC warning about the massive prescribing of psychotropic drugs to children in fourteen countries.[3] In response to the report submitted to one country, the U.N. body strongly recommended the establishment of a system for the "monitoring of the excessive use of psychostimulants to children." The UNCRC was critical of the "medicating" of children "without expressly examining root causes or providing parents and children with alternative support and therapy."[4] CCHR says a mental health "revolution" should start with an investigation into the more than one million 0-5 year olds prescribed psychiatric drugs, including 188,899 given stimulants in the U.S. An additional 4.1 million 6- 12-year-olds are also on psychiatric drugs, according to information obtained from IMS Health.

In his recent report, Mr. Pūras warns that power and decision-making in mental health are concentrated in the hands of "biomedical gatekeepers," particularly those representing biological psychiatry.[5] CCHR's submissions to the UNCRC had raised concerns about this biomedical emphasis.

The United States has one of the highest rates in the world of children prescribed psychostimulants, with 4.4 million children and adolescents on the drugs.[6] In May, QuintilesIMS Institute released the 2016 U.S. ADHD drugs sales and prescription information. ADHD drugs were the 13th highest class in prescriptions at 91 million, up 4.6 percent from 87 million in 2015 and nearly 20 percent from 76 million prescriptions in 2012. Sales of ADHD drugs were $11.2 billion in 2016.[7]

CCHR says the reliance upon the biomedical model is putting children at risk. A study published online in March 2017 in the Journal of Child Psychology and Psychiatry found that ADHD drugs such as methylphenidate and amphetamine-dextroamphetamine are not only ineffective in long-term treatment of "ADHD symptoms" but also can suppress growth if taken into adulthood.[8] Other adverse effects reported to the Food and Drug Administration (FDA) are recorded on CCHR's psychiatric drugs side effects database.

A "Revolutionary" Approach to "ADHD"

According to the watchdog group, the U.S. should look to approaches overseas, in particular Western Australia and Dr. Martin Whitely, former Member of Parliament (MP) and teacher who challenged the monitoring of psychostimulants given children in his state. In 2012, Allen Francis, a U.S. Duke University professor of psychiatry emeritus, writing in The Huffington Post said that Martin Whitely "offers a proven public health cure for this false 'epidemic' of diagnosis and treatment [of ADHD], one that has already worked wonders in his native state of Western Australia." The MP's work caused a massive downturn in child prescribing rates after calling for greater accountability of psychostimulant prescriptions to children. "The resulting more rigorous and independently administered accountability resulted in a dramatic and sustained (60-70 percent) fall in child ADD prescribing numbers," Dr. Whitely stated.[9]

Dr. Whitely helped in the release of a groundbreaking study on the long-term outcomes associated with stimulants in the treatment of ADHD. Known as the Raine study, researchers tracked children from birth to age 14 in Western Australian (WA). Published in February 2010, it provided the world's first independent data on the long-term effects (eight years) of psychostimulants prescribed to treat "ADHD." It found that amongst children who had been diagnosed with ADHD, those "medicated" with stimulants had significantly worse outcomes than those "never medicated." Specifically those drugged were 10.5 times more likely to be failing school than those never drugged. Researchers also found that stimulants may predispose children to the risk of heart attacks and stroke.[10]

Like many experts, Whitely points to the subjective means of diagnosing ADHD that underlies the epidemic of child drugging, saying that "ordinary behaviors like losing things, fidgeting, being forgetful, distracted or impulsive are turned into symptoms for concocted 'disorders' like ADHD. They are not symptoms, they are behaviors; perfectly normal behaviors, especially for children. In some cases they may require some attention, love and/or discipline, but they don't require amphetamines."[11] 

This subjectivity has also raised criticism within psychiatry itself. In 2013, Professor Frances, who was former head of the American Psychiatric Association's Diagnostic and Statistical Manual for Mental Disorders (DSM) IV Task Force, said the manual and new drugs that were aggressively marketed were responsible for rates of ADHD that tripled in the United States over 15 years.[12] He called it a "false epidemic" of ADHD.[13] The most recent APA manual says: "No biological marker is diagnostic for ADHD."[14]

After leaving politics, Dr. Whitely completed his Ph.D. thesis in 2014 at the John Curtin Institute of Public Policy in Western Australia on the subject of ADHD policy and practice in Australia.[15] He has also written the book "Speed Up and Sit Still: The Controversies of ADHD Diagnosis and Treatment."

In 2016, a series regarding the "future of mental health" published in Psychology Today, included an interview with Dr. Whitely, who stated: "Psychiatric diagnoses rarely involve identifying a cause and virtually never involve finding a cure."[16] A key to "changing the dominant 'label and drug' paradigm," he recommended, "is confronting the disease mongers and debunking their pseudoscience. Another key is to demand from our politicians that our regulators are independent and guided by robust science."[17] 

The article further quoted Dr. Whitely: "Drugging distracted kids with amphetamines and similarly dangerous drugs is disgraceful. Twenty years from now adults will look back and wonder what their parent's generation was thinking."[18] 

In January 2017, a study published the findings of a research team led by Dr. Whitely which analyzed data from 311,384 West Australian students aged 6 to 10 and 11 to 15. Of these, 5,937 received psychostimulants or other ADHD drugs. Among kids aged 6-10, those born in June, the last month of the recommended school intake, were twice as likely to have been given ADHD drugs as those born in July, the first month of the recommended intake. A similar difference was found in the 11-15 age group. "Similar findings in North America indicated that developmental immaturity is mislabeled as a mental disorder and unnecessarily treated with stimulant medication," the researchers reported in Medical Journal of Australia.[19] In 2016, Dr. Whitely said, "Nothing demonstrates what a nonsense diagnosis ADHD is better than the now well-established late birthdates effects. Four (soon to be five) large-scale international studies have established that children who are born in the later months of their school year cohort are far more likely to be labeled ADHD and drugged than their older classmates."[20] 

Dr. Whitely is aware of the need for more public awareness, pointing to "the most influential exposé of psychiatric excess in the 1970s was One Flew over the Cuckoo's Nest. We need similar exposés that both entertain and educate," he said.[21] With that, he and a talented young Australian film maker Ben Kosterich and others produced the "mockumentary," ADHD is BS (Behavioral Science). The mockumentary uses entertainment to educate that there is no biological marker to diagnose ADHD and the criteria are so broad as to enable any child to be diagnosed with the "disorder."[22]

CCHR says that U.S. legislators could learn from Dr. Whitely's experience. "For most politicians, mental health is a mysterious field. Many believe we need to do something about mental health; however, very few have any concept of what needs to be done. As a consequence, they rely heavily on 'experts' for advice. This is standard practice as politicians can't be experts in everything they are required to make decisions about," Dr. Whitely said.[23] 

CCHR says a national inquiry is needed into the high numbers of American children, especially those younger than 12, being prescribed psychotropic drugs. CCHR was instrumental in obtaining the 2004 Federal Child Medication Safety amendment, which gives parents the right to refuse psychiatric drugs for their children as a provision for attending school. They want to see the law expanded beyond the education system and for governments to act on a UNCRC recommendation to "put a stop to the practice of labeling of children as 'having a psychiatric problem,' in cases that are not validated by medical evidence."[24] This would be a start to reverse what Dr. Pūras describes as "a failure to integrate evidence and the voices of those most affected into policy, and a failure to respect, protect and fulfill the right to health."[25] 

CCHR is an independent mental health industry watchdog organization that works for patient protections and encourages the public to take action against mental health abuse. In the course of its 48 years it has helped get more than 180 laws enacted. It was established by the Church of Scientology and Professor of Psychiatry Thomas Szsaz in 1969 and today has an advisory board from diverse fields, including mental health, psychology, medicine, law, education and the arts. CCHR emphasizes that no one wanting to stop taking a psychiatric drug should do so without medical consultation and supervision.

Contact: Amber Rauscher, [email protected] or (323) 467-4242.

References:

[1]"World needs 'revolution' in mental health care – UN rights expert,"http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=21689&LangID=E#sthash.MMIxDbIx.dpuf; http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=21689&LangID=E.

[2] http://www.ohchr.org/EN/Issues/Health/Pages/SRBio.aspx

[3] The countries were Australia, Belgium, Canada, Finland, Germany, The Netherlands, Japan, Norway, Russia, Sweden, Denmark, Iceland, Spain, and Switzerland.

[4] "Consideration of reports submitted by States parties under article 44 of the Convention," UNCRC, 17 Sept. – 5 Oct. 2012, P. 15, http://rightsofchildren.ca/wp-content/uploads/Canada_CRC-Concluding-Observations_61.2012.pdf.

[5] "World needs 'revolution' in mental health care – UN rights expert,"http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=21689&LangID=E#sthash.MMIxDbIx.dpuf; http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=21689&LangID=E.

[6] https://www.cchrint.org/psychiatric-drugs/children-on-psychiatric-drugs/

[7] "Medicines Use and Spending in the U.S.: A Review of 2016 and Outlook to 2021" Quintiles IMS Institute, May 2017, p. 37.

[8] https://www.cchrint.org/2017/04/05/study-shows-long-term-use-of-adhd-drugs-ineffective-as-treatment-but-do-cause-growth-suppression/; Swanson JM, et al., "Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression," J Child Psychol Psychiatry, 10 Mar 2017, https://www.ncbi.nlm.nih.gov/pubmed/28295312.

[9] Allen Frances, "Taming the ADD Epidemic," Huffington Post, 31 Oct. 2012, http://www.huffingtonpost.com/allen-frances/add-epidemic-_b_1293556.html.

[10] ttp://www.health.wa.gov.au/publications/documents/MICADHD_Raine_ADHD_Study_report_022010.pdf; http://speedupsitstill.com/2011/02/20/raine-study-review-one-year-on/.

[11] Eric R. Maisel Ph.D., "Martin Whitely on ADHD: On the future of mental health," Psychology Today, 22 Mar. 2016, https://www.psychologytoday.com/blog/rethinking-mental-health/201603/martin-whitely-adhd.

[12] "Does your child really have a behaviour disorder? A shocking book by a leading therapist reveals how millions of us – including children – are wrongly labeled with psychiatric problems," Daily Mail, 6 May 2013, http://www.dailymail.co.uk/health/article-2320493/Does-child-really-behaviour-disorder-A-shocking-book-leading-therapist-reveals-millions--including-children--wrongly-labelled-psychiatric-problems.html#ixzz2SciDb8UA.

[13] Winston Chung, "Be prudent in diagnosing, medicating ADHD," San Francisco Chronicle, 14 May 2013, www.sfgate.com/health/article/Be-prudent-in-diagnosing-medicating-ADHD-4477451.php.

[14] Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5), (American Psychiatric Association, Arlington, VA 2013), p. 61.

[15] http://speedupsitstill.com/wp-content/uploads/2015/11/Martin-Whitely-PhD-Thesis-Copy-ADHD-and-Regulatory-Capture-in-Australia-PDF1.pdf.

[16] Op. cit., Eric R. Maisel, Ph.D., https://www.psychologytoday.com/blog/rethinking-mental-health/201603/martin-whitely-adhd.

[17] Ibid.

[18] Ibid.

[19] http://www.mentalhealthexcellence.org/adhd-children-may-be-immature/.

[20] Op. cit., Eric R. Maisel, Ph.D.

[21] Ibid.

[22] http://www.adhdisbs.com/adhd-facts/

[23] Op. cit., Eric R. Maisel, Ph.D.

[24] United Nations Convention on the Rights of the Child, Concluding observations on the combined third and fourth periodic reports of Germany, CRC/C/DEU/CO/3-4, 25 Feb 2014, http://tbinternet.ohchr.org/_layouts/treatybodyexternal/Download.aspx?symbolno=CRC/C/DEU/CO/3-4&Lang=En.

[25] "World needs 'revolution' in mental health care – UN rights expert,"http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=21689&LangID=E#sthash.MMIxDbIx.dpuf; http://www.ohchr.org/EN/NewsEvents/Pages/DisplayNews.aspx?NewsID=21689&LangID=E.

Related Links
About CCHR
Parents: Get the Facts—Know Your Rights

SOURCE Citizens Commission on Human Rights

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.